#Metsera

Pfizer and Metsera's Amended Merger Agreement: What It Means for Shareholders Pfizer's revised merger agreement with Metsera, valuing shares at $86.25, is poised to create significant value for shareholders. The Board's unanimous recommendation signals optimism for the deal's success.

4 months ago

Pfizer and Metsera's Amended Merger Agreement: What It Means for Shareholders #None #Merger #Pfizer #Metsera

0 0 0 0

4 months ago

The battle for obesity drug developer #Metsera rumbles on, with #Pfizer reported to have now matched #NovoNordisk's $10 billion offer as the US #financialregulator said questions need to be answered about the legality of Novo's bid.

pharmaphorum.com/news/pfizer-...

0 0 0 0

Metsera Responds Effectively to Recent Litigation Ruling by Delaware Court Metsera, Inc. confidently addresses a Delaware Court ruling related to litigation by Pfizer, asserting their commitment to shareholder interests.

4 months ago

Metsera Responds Effectively to Recent Litigation Ruling by Delaware Court #Litigation #Pfizer #Metsera

0 0 0 0

@pharmalot.bsky.social

4 months ago

FTC raises concern about Novo Nordisk attempt to acquire obesity startup Metsera The FTC has raised concerns about Novo Nordisk’s attempt to outbid Pfizer to acquire obesity startup Metsera.

FTC raises concern about Novo Nordisk attempt to acquire obesity startup Metsera.. statnews.com/pharmalot/20... #pharma #antitrust #FTC #obesity #weight #Pfizer #Metsera #NovoNordisk

0 0 0 0

Shareholder Alert: Actions Required Before Key Votes for CyberArk, TEGNA, Metsera, and Guess? Shareholder attention is drawn to critical upcoming votes regarding CyberArk, TEGNA, Metsera, and Guess?. Key actions are urged for affected parties.

4 months ago

Shareholder Alert: Actions Required Before Key Votes for CyberArk, TEGNA, Metsera, and Guess? #United_States #New_York #CyberArk #TEGNA #Metsera

0 0 0 0

Bidding war breaks out as Novo raises Metsera bid to $10bn Metsera has now received new takeover bids from both Pfizer and Novo Nordisk, and has plumped for a sweetened $10bn offer from the latter.

4 months ago

Obesity drug developer #Metsera has now received updated #takeover #offers from both #Pfizer and #NovoNordisk, and has come down in favour of a sweetened $10 billion bid from the latter.

pharmaphorum.com/news/bidding...

0 0 0 0

Novo Nordisk Outbids Pfizer in Acquisition Proposal for Metsera Metsera's board has declared Novo Nordisk's latest acquisition proposal superior, valuing the company at $10 billion, surpassing Pfizer's offer.

4 months ago

Novo Nordisk Outbids Pfizer in Acquisition Proposal for Metsera #United_States #New_York #Novo_Nordisk #Pfizer #Metsera

0 0 0 0

@papainvestor.bsky.social

4 months ago

#Pfizer is leaving no stone unturned in its efforts to prevent #NovoNordisk from stealing off with #Metsera, the weight-loss therapy developer it is hoping to acquire in a deal worth up to $7.3 billion.

pharmaphorum.com/news/pfizer-...

0 0 0 0

4 months ago

Pfizer ramps up the fight! Files 2nd lawsuit vs. Novo Nordisk & Metsera, claiming their $9B bid is anticompetitive & violates antitrust laws—aiming to "kill" competition in GLP-1 drugs for obesity/diabetes. Drama in pharma world! #Pfizer #NovoNordisk #Metsera

0 0 0 0

David Gaffen 🇺🇸🕊️✡️

@davidgaffen.bsky.social

4 months ago

Buying Tylenol for Headaches This may be the first time in history where someone bought Tylenol to give themselves a headache. But Kimberly Clark might have done it with a $40 billion deal to buy Kenvue, the Tylenol maker that ha...

It's Monday, which means another Business of America has landed! #Tylenol #AI #Metsera #OpenAI #Nvidia and anything else on my mind. Huzzah. Happy November.

www.linkedin.com/pulse/buying...

1 0 0 0

Metsera Responds Firmly to Litigation Filed by Pfizer Over Acquisition Attempts In light of Pfizer's recent litigation against Metsera, the company's board reaffirms its commitment to shareholders, rejecting Pfizer's tactics in the acquisition bid.

4 months ago

Metsera Responds Firmly to Litigation Filed by Pfizer Over Acquisition Attempts #USA #New_York #Litigation #Pfizer #Metsera

0 0 0 0

Pfizer sues to block Novo Nordisk's Metsera takeover bid Pfizer has filed a lawsuit to block a rival, higher bid for obesity therapy developer Metsera from Novo Nordisk, claiming it is anti-competitive.

4 months ago

#Pfizer has filed a #lawsuit against #NovoNordisk and #Metsera in an attempt to force through its #takeover of the weight-loss drug developer and prevent Novo Nordisk from taking its rival bid forward.

pharmaphorum.com/news/pfizer-...

0 0 0 0